COMMUNIQUÉS West-GlobeNewswire

Spine Injury Solutions Announces Results for the Fiscal First Quarter Ended March 31, 2018
14/05/2018
HOUSTON, May 14, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), today announced financial results for its Fiscal 2018 first quarter ended March 31, 2018. Financial Highlights Revenues for the [...]
Ossur Hf : Transactions in relation to share buyback program
14/05/2018
Announcement no. 35/2018 Reykjavik, 14 May 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
14/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 14 MAY 2018 at 18.30 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 avril 2018
14/05/2018
Communiqué de presse Villepinte, le 14 mai 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors
14/05/2018
SAN ANTONIO, May 14, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Peter S. Knight, founding [...]
Incysus Announces Appointment of Joy Bessenger as Senior Vice President, Finance and Strategy
14/05/2018
NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced today [...]
Eckert & Ziegler BEBIG: Convening Notice of the Annual General Meeting of Shareholders
14/05/2018
Eckert & Ziegler BEBIG SA Industrial Zone C, 7180 Seneffe VAT BE 457.288.682 Register of Legal Entities Hainaut - Division Charleroi www.bebig.com (the " Company ") CONVENING NOTICE OF THE ANNUAL GENERAL MEETING OF [...]
Eckert & Ziegler BEBIG: Convocation à l'Assemblée Générale Ordinaire des Actionnaires
14/05/2018
Eckert & Ziegler BEBIG SA Zone Industrielle C, 7180 Seneffe TVA BE 457.288.682 Registre des personnes morales Hainaut - Division Charleroi www.bebig.com (la " Société ") CONVOCATION A L'ASSEMBLEE GENERALE ORDINAIRE [...]
Novo Nordisk A/S - Share repurchase programme
14/05/2018
Bagsværd, Denmark, 14 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
ORYZON announces First Patients In ETHERAL: a Phase IIa clinical trial in Alzheimer’s Disease with ORY-2001
14/05/2018
The trial was approved in Spain in April and in France last week First three patients included in Spain last week This is the second Phase IIa study in a CNS indication with the drug MADRID, Spain and CAMBRIDGE, Mass., [...]
Oncobiologics Announces $15 Million Private Placement Offering
14/05/2018
CRANBURY, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS ) (the “Company”) today announced that on May 11, 2018, it entered into a purchase agreement with GMS Tenshi Holdings Pte. Limited (“GMS [...]
Sienna Biopharmaceuticals Reports First Quarter 2018 Financial Results
14/05/2018
WESTLAKE VILLAGE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today reported the Company’s financial results for the first quarter of 2018. “We are pleased to report the [...]
Galectin Therapeutics Proceeds to Phase 3 Development of GR-MD-02 for NASH Cirrhosis Following FDA Meeting
14/05/2018
NORCROSS, Ga., May 14, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, announced today it is proceeding with plans for a Phase 3 [...]
OrthoPediatrics Corp. Announces FDA 510(k) Clearance for its 25th Surgical System, Pediatric Nailing Platform |FEMUR
14/05/2018
WARSAW, Ind., May 14, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce U.S. Food and Drug [...]
Get the Best Bang for Your Buck with BlueChew, the First Ever Chewable Sildenafil and Tadalafil Tablet
14/05/2018
No doctor visit needed—this online, subscription-based alternative makes better sex easier than ever CHICAGO, May 14, 2018 (GLOBE NEWSWIRE) -- Things are looking up… New online subscription service BlueChew today [...]
Advantis Corp. Creates Synergy with Herb N Works
14/05/2018
NEWPORT BEACH, CA, May 14, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) announced it is finalizing a contract to acquire a percentage of Herb N Works, the premier creative branding and marketing [...]
DBV Technologies Partners with FARE to Help Raise Awareness of Food Allergies in Support of the 21st Anniversary of Food Allergy Awareness Week
14/05/2018
Montrouge, France, May 14, 2018 DBV Technologies Partners with FARE to Help Raise Awareness of Food Allergies in Support of the 21 st Anniversary of Food Allergy Awareness Week DBV Technologies (Euronext: DBV - ISIN: [...]
DBV Technologies s'associe à FARE pour sensibiliser la population au sujet des allergies alimentaires lors du 21e anniversaire de la Semaine nationale des allergies alimentaires
14/05/2018
Montrouge, France, le 14 mai (14h30 CEST) 2018 DBV Technologies s'associe à FARE pour sensibiliser la population au sujet des allergies alimentaires lors du 21 e anniversaire de la Semaine nationale des allergies [...]
PolarityTE Acquires Operating GLP/USDA Preclinical Biomedical Research Facility and Announces Caroline Garrett DVM from Johns Hopkins as Chief Veterinary Officer at Polarity
14/05/2018
SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (NASDAQ: COOL ) announced the acquisition of a preclinical biomedical research facility in order to accelerate research and development of PolarityTE [...]

Pages